Hims & Hers Health, Inc. (HIMS)
- Previous Close
12.33 - Open
12.46 - Bid 12.27 x 2200
- Ask 12.42 x 1400
- Day's Range
12.15 - 12.60 - 52 Week Range
5.65 - 17.16 - Volume
2,949,740 - Avg. Volume
5,120,351 - Market Cap (intraday)
2.644B - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
-- - EPS (TTM)
-0.11 - Earnings Date May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.71
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
www.forhims.com1,046
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HIMS
Performance Overview: HIMS
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HIMS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HIMS
Valuation Measures
Market Cap
2.64B
Enterprise Value
2.43B
Trailing P/E
--
Forward P/E
204.08
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.96
Price/Book (mrq)
7.68
Enterprise Value/Revenue
2.79
Enterprise Value/EBITDA
-121.91
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.70%
Return on Assets (ttm)
-4.03%
Return on Equity (ttm)
-7.18%
Revenue (ttm)
872M
Net Income Avi to Common (ttm)
-23.55M
Diluted EPS (ttm)
-0.11
Balance Sheet and Cash Flow
Total Cash (mrq)
220.98M
Total Debt/Equity (mrq)
2.89%
Levered Free Cash Flow (ttm)
66.65M